Journals / Türk Geriatri Dergisi / 2010 / Cilt: 13 - Sayı: 2

Relationship between painful diabetic polyneuropathy and hypertriglyceridemia and hypercholesterolemia

Ağrılı diyabetik polinoropati ile hipertrigliseridemi ve hiperkolesterolemi ilişikisi

Pages
73–78
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In conclusion, although no statistical significance was found between painful diabetic polyneuropathy and hypertriglyceridemia/hypercholesterolemia, triglyceride levels were found to be increased.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: The presence of lipid metabolism disorders in diabetic and painful neuropathies,and the existence of some observations and articles supporting this coexistence states a doubt whether there is a correlation between painful diabetic neuropathy and lipid metabolism disorder.
📊
Key Findings & Data:Materials and Method: Our study included a patient group of 90 who were diagnosed with diabetic neuropathy and a control group of 20 patients without diabetic neuropathy who had mild paresthetic complaints and hyperlipidemia.
💡
Conclusion & Impact:Conclusion: In conclusion, although no statistical significance was found between painful diabetic polyneuropathy and hypertriglyceridemia/hypercholesterolemia, triglyceride levels were found to be increased.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: The presence of lipid metabolism disorders in diabetic and painful neuropathies,and the existence of some observations and articles supporting this coexistence states a doubt whether there is a correlation between painful diabetic neuropathy and lipid metabolism disorder. This study was planned to investigate the relation between lipid metabolism and peripheral neuropathy. Materials and Method: Our study included a patient group of 90 who were diagnosed with diabetic neuropathy and a control group of 20 patients without diabetic neuropathy who had mild paresthetic complaints and hyperlipidemia. Patients were evaluated with a detailed history of the illness and neurological examination, total neuropathy score, EMG, fasting blood glucose, HbA1c, total blood cholesterol and triglyceride levels. Results: In 49 out of 90 patients, painful diabetic neuropathy was diagnosed. The groups with and without pain were compared and tested for presence of correlation. Significant associations with fibular nerve response amplitude and cholesterol levels were found (p=0.006) while no correlations with triglyceride levels were observed (p=0.827). The blood lipid levels, especially triglyceride levels, were found to be increased both in painful diabetic neuropathy patients and the ones with positive sensory symptoms. Conclusion: In conclusion, although no statistical significance was found between painful diabetic polyneuropathy and hypertriglyceridemia/hypercholesterolemia, triglyceride levels were found to be increased. This finding warrants further investigation on this subject.

Özet

Giriş: Diyabetik ve ağrılı noropatisi olan hastalarda lipid metabolizma bozukluğunun varlığı ve bu iki durumun birlikteliğini destekleyen bazı gözlem ve araştırmaların varoluşlu ağrılı diyabetik polinoropati ve lipid metabolizma bozukluğu arasında bir korelasyon olduğunu akla getirmektedir. Lipid metabolizması ve periferik noropati hakkında yeterli sayıda medikal kayıt ve makale bulunmamaktadır. Gereç ve Yöntem: Bu calışma, diyabetik noropati ön tanılı 90 kişlilik hasta grubu ve ılımlı duzeyde parestetik yakınması ve hiperlipidemisi olan fakat noropati tespit edilmeyen 20 kişililik kontrol grubu ile yapılmışltır. Hastalar ayrıntılı öykü, norolojik muayene, Total Noropati Skoru ile değerlendirilmiş olup EMG yapılmış ve aclık kan şekeri, HbA1c, total kolesterol, trigliserid duzeylerine bakılmıştırğ Bulgular: Hastaların 49’unda ağrılı diyabetik noropati tespit edilmiş, ağrısı olan grup ile ağ- rısı olmayan grup arasında lipid düzeyleri açısından karşılaştırma yapılmış ve korelasyon olup olmadığı na bakılmıştırğ Fibular sinir amplitudu ile kolesterol duzeyleri ile anlamlı ilişki bulunurken (p=0ğ006), trigliserid duzeyleri ile anlamlı bir korelasyon bulunmamıştır (p=0ğ827)ğ Ağrılı diyabetik noropatisi ve pozitif duysal semptomları olanlarda lipid duzeyleri, ozellikle de trigliserid duzeyleri yuksek bulunmuştur.Sonuç: Ağrılı diyabetik polinoropati ile hipertrigliseridemi /hiperkolesterolemi arasında istatistiksel ilişki olmasa da trigliserid seviyeleri yüksek bulunmuştur. Bulgular bu konuda ileri araştırmalara ihtiyaç olduğunu düşündürmüştür.

🔖

Cite This Article

ŞAHİN, Ş., ÖZTÜRK, S. M., KIZILTAN, M. (2022). Relationship between painful diabetic polyneuropathy and hypertriglyceridemia and hypercholesterolemia. Türk Geriatri Dergisi, Cilt: 13 - Sayı: 2, 73–78. https://ajindex.com/articles/624148

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Jensen TS Backonja MM, Hernández Jiménez S, Tesfaye S, Valensi P, Ziegler D. New perspectives on the management of diabetic peripheral neuropathic pain. Diab Vasc Dis Res 2006; 3(2): 108-19
  2. Harati Y. Frequently asked questions about diabetic peripheral neuropathies. Neurol Clin 1992;10(3):783– 807
  3. Mc Manis, PG Windebank AJ, Kiziltan M. Neuropathy associated with hyperlipidemia. Neurology 1994; 44: 2185-2186
  4. Fessel WJ. Fat Disorders and peripheral neuropathy. Brain 1971; 94: 531-540
  5. Pardal Refoya JL. Adiposis dolorosa– Dercum’s disease. An Otorinolaringol Ibero Am 1996; 23 (4): 43-44
  6. Amine B, Leguilchard F, Benhamou CL. Dercum’s disease (adiposis dolorosa): a new case-report. Joint Bone Spine 2004;71(2):147–149
  7. Brodovsky S, Westreich M, Leibowitz A, Schwartz Y. Adiposis Dolorosa (Dercum’s Disease): 10 year follow up. Ann Plast Surg 1994; 33 (6): 664-668
  8. Yao JK, Dyck PJ. Lipid abnormalities in hereditary neuropathy, Part 3. plasma and erythrocyte lipids of HMSN-III (Dejérine-Sottas Disease), J Neurol Sci, 1978, 38: 59-65
  9. Lemaire JF, Autret A, Biziere K, Romet-Lemone JL, Gray F. Amiodaron neuropathy: further arguments for human drug-induced neurolipidosis. Eur Neurol 1982; 21(1):65–68
  10. Poorabbas A, Fallah F, Bagdadchi J, et al. Determination of free L-carnitine levels in type II diabetic women with and without complications. Eur J Clin Nutr 2007;61(7):892–895
  11. Executive summary of the third report of the national cholesterol education program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285(19): 2486–2497
  12. Cornblath DR, Chaudhry V, Carter K, et al. Total neuropathy score validation and reliability study. Neurology 1999; 53: 1660-1664
  13. Powers AC. Diabetes mellitus. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL (Ed): Harrison’s Principles of Internal Medicine, 15th Edition. McGraw-Hill, New York, 2001, pp 2109–2138
  14. Horrobin DF, Carmichael HA. Essential fatty acids in relation to diabetes. In: Horrobin DF (Ed): Treatment of Diabetic Neuropathy: A new approach. Churchill Livingston, Edinburgh, 1992, pp 21–40
  15. Yao JK. Metabolic turnover of fatty acids and acylglycerols in rat sciatic nerve. J Neurochem 1985;45(2):589–595
  16. Yao JK, Holman RT, Lubozynski MF, Dyck PJ. Changes in fatty acid composition of peripheral nerve myelin in essential fatty acid deficiency. Arch Biochem Biophys 1980;204